← FDA Drug Approvals (Drugs@FDA)
DOXAZOSIN MESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2018-04-17
Drug application
- FDA Application #
ANDA209013
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXAZOSIN MESYLATE
- Generic name
- DOXAZOSIN MESYLATE
- Active ingredients
- DOXAZOSIN MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- SOMERSET THERAPS LLC
- Manufacturer
- Upsher-Smith laboratories, LLC
- First approval
- 2018-04-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown